title: Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndrome.
abstract: Wiskott-Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency caused by the defective expression of the WAS protein (WASP) in hematopoietic cells. It has been shown that dendritic cells (DCs) are functionally impaired in WAS patients and was(-/-) mice. We have previously demonstrated the efficacy and safety of a murine model of WAS gene therapy (GT), using stem cells transduced with a lentiviral vector (LV). The aim of this study was to investigate whether GT can correct DC defects in was(-/-) mice. As DCs expressing WASP were detected in the secondary lymphoid organs of the treated mice, we tested the in vitro and in vivo function of bone marrow-derived DCs (BMDCs). The BMDCs showed efficient in vitro uptake of latex beads and Salmonella typhimurium. When BMDCs from the treated mice (GT BMDCs) and the was(-/-) mice were injected into wild-type hosts, we found a higher number of cells that had migrated to the draining lymph nodes compared with mice injected with was(-/-) BMDCs. Finally, we found that ovalbumin (OVA)-pulsed GT BMDCs or vaccination of GT mice with anti-DEC205 OVA fusion protein can efficiently induce antigen-specific T-cell activation in vivo. These findings show that WAS GT significantly improves DC function, thus adding new evidence of the preclinical efficacy of LV-mediated WAS GT.
authors.affiliation: Vita-Salute San Raffaele University, Milan, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Catucci
authors.forename: F
authors.initials: F
authors.lastname: Prete
authors.forename: M
authors.initials: M
authors.lastname: Bosticardo
authors.forename: M C
authors.initials: MC
authors.lastname: Castiello
authors.forename: E
authors.initials: E
authors.lastname: Draghici
authors.forename: M
authors.initials: M
authors.lastname: Locci
authors.forename: M G
authors.initials: MG
authors.lastname: Roncarolo
authors.forename: A
authors.initials: A
authors.lastname: Aiuti
authors.forename: F
authors.initials: F
authors.lastname: Benvenuti
authors.forename: A
authors.initials: A
authors.lastname: Villa
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000276:immunology; D002465:Cell Movement; D003713:Dendritic Cells / Q000276:immunology* / Q000378:metabolism; D015316:Genetic Therapy; D006801:Humans; D016086:Lentivirus / Q000235:genetics*; D008221:Lymphoid Tissue / Q000378:metabolism; D051379:Mice; D008957:Models, Genetic; D010587:Phagocytosis; D014161:Transduction, Genetic; D014923:Wiskott-Aldrich Syndrome / Q000628:therapy*; D051316:Wiskott-Aldrich Syndrome Protein / Q000235:genetics* / Q000378:metabolism
chemical_list: D051316:Wiskott-Aldrich Syndrome Protein